Active Ingredient(s): Nateglinide
FDA Approved: * December 22, 2000
Pharm Company: * NOVARTIS
Category: Diabetes

Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis. Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs. Contents 1 Pharmacology 2 Contraindications 3 Comparisons with other drugs for type 2 diabetes 4 Dosage 5 See also 6 References 7 External links Pharmacology Nateglinide lowers blood glucose by stimulating the re... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Starlix STARLIX;60
Starlix 60 mg Oral Tablet
NDC: 0078-0351
Novartis Pharmaceuticals Corporation
Starlix STARLIX;120
Starlix 120 mg Oral Tablet
NDC: 0078-0352
Novartis Pharmaceuticals Corporation